secukinumab
novartis
['secukinumab', ' psa']
#spa #posters #acr22 1040. impact of weight and sex on long-term persistence to secukinumab in psa and as 3 y of follow-up: high persistence 63-68% higher prop of or pts w weight 90 kg discontinued trt due to lack of efficacy in psa uta kiltz #acrambassador 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books